® 0.25 "

: Certican ® 0.25 Mg Tablets. ?  »
|
-

PER OS

Tablets

Kidney and heart transplantationCertican ?® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.

132 60 31066 00

Novartis Pharma Stein Ag, Switzerland

02/2015 - 02/2025

.
, .
.
/
Everolimus 0.25 MG
Blister pvc/pa/aluminium 60 x TABLETS 36

*

*

 

.

 
" !
 

- !
:  »
190
-